Back to search Find a Tender

AWARD Complete

Next Generation Sequencing Testing (NGS)

Published 26 Oct 2026

26 Oct 2026

NHS Blood and Transplant

Primary CPV: 72225000 *
System quality assurance assessment and review services
Location: 🇬🇧 Bristol, City of, South West
Value: £407,200
Contract: 1 year Duration
13/10/2026 12/10/2027
Contract Types: 72 *IT services: consulting, software & supp...
Full CPV Breakdown
SME suitable: Not stated

Publisher Address

500 North Bristol Park, Bristol, BS34 7QH, United Kingdom · UKK11

Contact

rowena.thomas@nhsbt.nhs.uk

Award Criteria

Not specified

FULL DOCUMENTATION

Related tenders

NHS Blood and Transplant

All notices from this publisher

Same CPV code

72225000 *

All notices with this CPV code

Reference: C362396

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Awarded to

SGS UNITED KINGDOM LIMITED

Full CPV breakdown

72225000 — System quality assurance assessment and review services (primary)

Notice details

Buyer type: Central government
Competition: Open competition (any supplier can bid)
Contract type: Services
Winning supplier: Large company
Procurement method: Competitive flexible procedure
Main category: Services
Legal basis: UKPGA 2023/54
Notice status: Complete
Award status: Active
Covered by GPA: Yes
Language: EN
Published: 26 Oct 2026 08:28
OCID: ocds-h6vhtk-0514f8
Notice ID: C362396

Organisations on this notice

SGS United Kingdom Limited

Supplier Large

Inward Way, Rossmore Business Park, Ellesmere Port, CH65 3EN, United Kingdom

gb.bid.management@sgs.com

GB-PPON PLYM-7548-BZWR

Full notice record

68 details

Everything the publisher included in this notice, organised by section.

Organisations

Party 1 › Name	NHS Blood and Transplant
Party 1 › Address › Street	500 North Bristol Park
Party 1 › Address › Town / city	Bristol
Party 1 › Address › Postcode	BS34 7QH
Party 1 › Address › Country	GB
Party 1 › Address › Country	United Kingdom
Party 1 › Address › Region (NUTS)	UKK12
Party 1 › Contact › Email	rowena.thomas@nhsbt.nhs.uk
Party 1 › Role	buyer
Party 1 › Link	https://www.nhsbt.nhs.uk/
Party 1 › Classification › Description	Public authority - central government
Party 2 › Name	SGS United Kingdom Limited
Party 2 › Address › Street	Inward Way, Rossmore Business Park
Party 2 › Address › Town / city	Ellesmere Port
Party 2 › Address › Postcode	CH65 3EN
Party 2 › Address › Country	GB
Party 2 › Address › Country	United Kingdom
Party 2 › Address › Region (NUTS)	UKD63
Party 2 › Contact › Email	gb.bid.management@sgs.com
Party 2 › Role	supplier
Party 2 › Business size	large
Party 2 › VCSEs	No
Party 2 › Public service mission organisation	No
Party 2 › Sheltered workshop	No

Buyer

Name	NHS Blood and Transplant

Tender

Title	Next Generation Sequencing Testing (NGS)
Description	NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Status	complete
Procedure type	open
Procedure	Competitive flexible procedure
Covered by	GPA
Lot › Status	complete
Document › Document type	Conflict of interest
Document › Description	Not published

Awards

Status	active
Category	services
Supplier › Name	SGS United Kingdom Limited
Item › CPV › Description	System quality assurance assessment and review services
Item › Delivery › Region (NUTS)	UKK11
Item › Delivery › Country	GB
Item › Delivery › Country	United Kingdom

Contracts

Title	Next Generation Sequencing Testing (NGS)
Status	active
Contract period › Start	13 Oct 2026
Contract period › End	12 Oct 2027
Contract period › Can be extended to	12 Oct 2028
Can be renewed	Yes
Renewal › Description	Option to extend for 12 months
Has options	Yes
Options › Description	Option to extend for 12 months
Value › Value incl. VAT	£488,640
Value › Value	£407,200
Value › Currency	GBP
Above threshold	Yes
Signed	13 Oct 2026
Agreed Metrics › Agreed Metric 1 › Title	Turnaround Time – NGS Analysis
Agreed Metrics › Agreed Metric 1 › Description	Supplier to complete NGS analysis and issue the approved report within 3 weeks of receipt of a valid sample and all required information.
Agreed Metrics › Agreed Metric 1 › Observations › Contract period › Duration In Months	3
Agreed Metrics › Agreed Metric 2 › Title	Turnaround Time – E.coli Culture / DNA Extraction where required
Agreed Metrics › Agreed Metric 2 › Description	Where E.coli culture / DNA extraction is required, Supplier to complete this stage within 1 week, before NGS analysis commences.
Agreed Metrics › Agreed Metric 2 › Observations › Contract period › Duration In Months	3
Agreed Metrics › Agreed Metric 3 › Title	Out-of-Specification / Non-Conformance Notification
Agreed Metrics › Agreed Metric 3 › Description	Supplier to notify NHSBT of a major OOS event or major non-conformance within one business day, including the nature of the issue, immediate containment actions and next steps.
Agreed Metrics › Agreed Metric 3 › Observations › Contract period › Duration In Months	3
Document › Document type	Contract notice
Document › Description	Contract details notice on Find a Tender
Document › Link	https://www.find-tender.service.gov.uk/Notice/100796-2026
Document › Published	26 Oct 2026

Track this tender

Track this tender in your bid pipeline and set reminders.

See plans